Stem Cell Transplantation As a Progressing Treatment for Retinitis Pigmentosa

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Stem Cell Transplantation As a Progressing Treatment for Retinitis Pigmentosa Publisher Pubmed

Hosseini Shabanan S¹ ; Seyedmirzaei H^{1, 2, 3} ; Barnea A⁴ ; Hanaei S^{1, 2, 3} ; Rezaei N^{1, 2, 3}

Source: Cell and Tissue Research Published:2022

Abstract

Retinal degenerative diseases such as retinitis pigmentosa (RP) are of the major causes of vision loss in developed countries. Despite the unclear pathophysiology, treatment methods have been investigated vastly in the past decades. This review article mainly discusses the advances in application of stem cell and progenitor transplantation for retinitis pigmentosa. Stem cell sources such as mesenchymal stem cells, embryonic stem cells, induced pluripotent stem cells, neural stem cells, retinal progenitor cells, and olfactory ensheathing cells are discussed separately in addition to a brief description of two approaches for treatment of early-stage RP, including gene therapy and nutritional therapy. © 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Related Docs

View other Related Docs

1. Cell Therapy for Retinal Degenerative Disorders: A Systematic Review and Three-Level Meta-Analysis, Journal of Translational Medicine (2024)

2. Retinal Tissue Engineering: Regenerative and Drug Delivery Approaches, Current Stem Cell Research and Therapy (2023)

3. X-Linked Retinitis Pigmentosa Gene Therapy: Preclinical Aspects, Ophthalmology and Therapy (2023)

Experts (# of related papers)

View all Related Experts

Farzad Pakdel (3)

Somayeh Ebrahimi Barough (2)

Other Related Docs

4. Neurosphere-Free Transdifferentiation of Rat Bone Marrow Stromal Stem Cells Into Retinal Cells and Retinal Pigment Epithelium, Basic and Clinical Neuroscience (2021)

5. Cell-Based Approaches Towards Treating Age-Related Macular Degeneration, Cell and Tissue Banking (2020)

6. High Efficient Differentiation of Human Adipose-Derived Stem Cells Into Retinal Pigment Epithelium-Like Cells in Medium Containing Small Molecules Inducers With a Simple Method, Tissue and Cell (2019)

7. Fibrin Gel As a Scaffold for Photoreceptor Cells Differentiation From Conjunctiva Mesenchymal Stem Cells in Retina Tissue Engineering, Artificial Cells# Nanomedicine and Biotechnology (2018)

8. Effects of Fresh Bone Marrow Mononuclear Cell Therapy in Rat Model of Retinopathy of Prematurity, Regenerative Therapy (2023)

9. Extracellular Vesicles Derived From Human Es-Mscs Protect Retinal Ganglion Cells and Preserve Retinal Function in a Rodent Model of Optic Nerve Injury, Stem Cell Research and Therapy (2020)

10. Dental Pulp Stem Cells Differentiation Into Retinal Ganglion-Like Cells in a Three Dimensional Network, Biochemical and Biophysical Research Communications (2015)

11. Mouse Degenerating Optic Axons Survived by Human Embryonic Stem Cell-Derived Neural Progenitor Cells, Cell Journal (2022)

12. Cataract Surgery in Patients With Retinitis Pigmentosa: Systematic Review, Journal of Cataract and Refractive Surgery (2023)

13. Clinical Cell Therapy Guidelines for Neurorestoration (Ianr/Canr 2022), Journal of Neurorestoratology (2022)

14. Retina Tissue Engineering by Conjunctiva Mesenchymal Stem Cells Encapsulated in Fibrin Gel: Hypotheses on Novel Approach to Retinal Diseases Treatment, Medical Hypotheses (2017)

15. Effects of Fibrin Glue As a Three-Dimensional Scaffold in Cultivated Adult Human Retinal Pigment Epithelial Cells, Journal of Biomaterials Applications (2018)

16. Evaluating the Impact of Mesenchymal Stem Cell Therapy on Visual Acuity and Retinal Nerve Fiber Layer Thickness in Optic Neuropathy Patients: A Comprehensive Systematic Review and Meta-Analysis, BMC Ophthalmology (2024)

17. Reprogramming of Endometrial Adult Stromal Cells in the Presence of a Rock Inhibitor, Thiazovivin, Could Obtain More Efficient Ipscs, Cell Biology International (2015)

18. A Review on Leukemia and Ipsc Technology: Application in Novel Treatment and Future, Current Stem Cell Research and Therapy (2018)

19. Applying Differentiated Retinal Cell for Age-Related Macular Degeneration Treatment, Iranian Journal of Chemistry and Chemical Engineering (2022)

20. Erythropoietin Protects Against Retinal Damage in a Rat Model of Optic Neuropathy Via Glial Suppression, Cell Journal (2023)

Style	Citing Format
MLA	Hosseini Shabanan S, et al.. "Stem Cell Transplantation As a Progressing Treatment for Retinitis Pigmentosa." Cell and Tissue Research, vol. 387, no. 2, 2022, pp. 177-205.
APA	Hosseini Shabanan S, Seyedmirzaei H, Barnea A, Hanaei S, Rezaei N (2022). Stem Cell Transplantation As a Progressing Treatment for Retinitis Pigmentosa. Cell and Tissue Research, 387(2), 177-205.
Chicago	Hosseini Shabanan S, Seyedmirzaei H, Barnea A, Hanaei S, Rezaei N. "Stem Cell Transplantation As a Progressing Treatment for Retinitis Pigmentosa." Cell and Tissue Research 387, no. 2 (2022): 177-205.
Harvard	Hosseini Shabanan S et al. (2022) 'Stem Cell Transplantation As a Progressing Treatment for Retinitis Pigmentosa', Cell and Tissue Research, 387(2), pp. 177-205.
Vancouver	Hosseini Shabanan S, Seyedmirzaei H, Barnea A, Hanaei S, Rezaei N. Stem Cell Transplantation As a Progressing Treatment for Retinitis Pigmentosa. Cell and Tissue Research. 2022;387(2):177-205.
BibTex	@article{ author = {Hosseini Shabanan S and Seyedmirzaei H and Barnea A and Hanaei S and Rezaei N}, title = {Stem Cell Transplantation As a Progressing Treatment for Retinitis Pigmentosa}, journal = {Cell and Tissue Research}, volume = {387}, number = {2}, pages = {177-205}, year = {2022} }
RIS	TY - JOUR AU - Hosseini Shabanan S AU - Seyedmirzaei H AU - Barnea A AU - Hanaei S AU - Rezaei N TI - Stem Cell Transplantation As a Progressing Treatment for Retinitis Pigmentosa JO - Cell and Tissue Research VL - 387 IS - 2 SP - 177 EP - 205 PY - 2022 ER -

Science Communicator Platform

Authors

Abstract